MEDTRONIC NEUROMODULATION FDA Inspection Record

FEI 2182207 · Inspections, Form 483s, warning letters and import refusals

MEDTRONIC NEUROMODULATION is an FDA-registered facility (FEI 2182207) located in Minneapolis, MN, US. RegDataLab tracks 15 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
May 5, 2023: Voluntary Action Indicated (VAI)
Inspections on record
15 (2 OAI, 8 VAI, 5 NAI)
Last OAI inspection
Apr 3, 2013
Warning letters
1 listed by FDA for this FEI, latest Jul 17, 2012
Recalls as the recalling firm
70, latest Sep 8, 2026
Import refusals
4

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 15 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 5, 2023Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Investigation of device failures (21 CFR 820.198(c))
Time to report - 10 days (21 CFR 806.10(b))
Lack of System for Event Evaluations (21 CFR 803.17(a)(1))
Nov 3, 2022Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Report of risk to health (21 CFR 806.10(a)(1))
Sep 9, 2021No Action Indicated (NAI)No citations listed
Oct 17, 2019Voluntary Action Indicated (VAI)Design input - documentation (21 CFR 820.30(c))
Lack of or inadequate procedures (21 CFR 820.100(a))
Aug 6, 2019No Action Indicated (NAI)No citations listed
Jun 21, 2018No Action Indicated (NAI)No citations listed
Jun 30, 2017Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Investigation of device failures (21 CFR 820.198(c))
Jun 7, 2017Voluntary Action Indicated (VAI)No citations listed
Oct 26, 2015Voluntary Action Indicated (VAI)Procedures not adequately established or maintained (21 CFR 820.40)
Nonconforming product control (21 CFR 820.90(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Report of risk to health (21 CFR 806.10(a)(1))
Dec 19, 2013Voluntary Action Indicated (VAI)No citations listed

Recalls

Showing the 10 most recent of 70 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 8, 2026Class IIZ-0266-2027InterStim SureScan MRI Leads 978A1 & 978B1: LEAD 978A128 ISTM MICRO 28CM SSMRI… and 1 more product
Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as…
May 13, 2026Class IIZ-2240-2026Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator… and 1 more product
A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Apr 8, 2026Class IIZ-2201-2026Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application…
Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be…
Dec 3, 2025Class IIZ-1043-2026A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683…
Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed…
Nov 20, 2025Class IIZ-0996-2026Restore Clinician Programmer Application (CP App), Model A71100 used with the following…
Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to…
Apr 3, 2025Class IIZ-1704-2025Enhanced Verify Evaluation Handset (CFN HH90130FA)
Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior…
Mar 4, 2025Class IIZ-1543-2025Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv…
There is a software issue that can permanently disable communication with an implantable neurostimulator (INS) when a specific…
Jan 9, 2025Class IIZ-1506-2025A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion…
Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable…
Nov 21, 2024Class IIZ-0771-2025SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG… and 3 more products
Software issues were identified in application version 2.x.
Sep 24, 2024Class IIZ-0206-2025Medtronic Percept RC Implantable Neurostimulators (INS), Model B35300.
A limited number of Percept RC Implantable Neurostimulators (INS), Model B35300 will not be able to communicate with the A610 DBS Clinician…

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 14, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 14, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 14, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 2, 2026Newest record Oct 22, 2026Current

Reviewing MEDTRONIC NEUROMODULATION as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check MEDTRONIC NEUROMODULATION yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Medtronic Neuromodulation
Location
Minneapolis, MN (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.